Lorenz Muller
Corporate Officer/Principal chez MILESTONE PHARMACEUTICALS INC.
Fortune : 238 761 $ au 31/03/2024
Profil
Lorenz Muller is currently the Chief Commercial Officer at Milestone Pharmaceuticals, Inc. He previously worked as the Executive Director-Thrombosis at Daiichi Sankyo, Inc. from 2008 to 2015, Vice President-Marketing & Healthcare Outcomes at CV Therapeutics, Inc. from 2001 to 2011, and Vice President-Marketing at EXACT Sciences Corp.
from 2016 to 2017.
Mr. Muller received his undergraduate and graduate degrees from Massachusetts Institute of Technology and his MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2023 | 133 386 ( 0,25% ) | 238 761 $ | 31/03/2024 |
Postes actifs de Lorenz Muller
| Sociétés | Poste | Début |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/10/2017 |
Anciens postes connus de Lorenz Muller
| Sociétés | Poste | Fin |
|---|---|---|
| EXACT SCIENCES CORPORATION | Sales & Marketing | 01/07/2017 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01/12/2015 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Sales & Marketing | 02/05/2011 |
Formation de Lorenz Muller
| Massachusetts Institute of Technology | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
